Literature DB >> 31392242

Second-Generation Antisense Nucleotide Targeting Huntingtin Expression Found to Be Safe in Patients With Huntington's Disease.

Alex Medina Escobar1, Veronica Bruno1, Justyna R Sarna1.   

Abstract

Entities:  

Keywords:  Huntingtin expression; Huntington's disease; antisense nucleotide; safety

Year:  2019        PMID： 31392242      PMCID： PMC6660221          DOI： 10.1002/mdc3.12803

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  3 in total

Review 1.  History of genetic disease: the molecular genetics of Huntington disease - a history.

Authors:  Gillian P Bates
Journal:  Nat Rev Genet       Date:  2005-10       Impact factor: 53.242

2.  Targeting Huntingtin Expression in Patients with Huntington's Disease.

Authors:  Sarah J Tabrizi; Blair R Leavitt; G Bernhard Landwehrmeyer; Edward J Wild; Carsten Saft; Roger A Barker; Nick F Blair; David Craufurd; Josef Priller; Hugh Rickards; Anne Rosser; Holly B Kordasiewicz; Christian Czech; Eric E Swayze; Daniel A Norris; Tiffany Baumann; Irene Gerlach; Scott A Schobel; Erika Paz; Anne V Smith; C Frank Bennett; Roger M Lane
Journal:  N Engl J Med       Date:  2019-05-06       Impact factor: 91.245

Review 3.  Therapies targeting DNA and RNA in Huntington's disease.

Authors:  Edward J Wild; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2017-09-12       Impact factor: 44.182
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.